ERK1/2 achieves sustained activation by stimulating MAPK phosphatase-1 degradation via the ubiquitin-proteasome pathway.

Source:http://linkedlifedata.com/resource/pubmed/id/12676937

J. Biol. Chem. 2003 Jun 13 278 24 21534-41

Download in:

View as

General Info

PMID
12676937